Neurochemical in vivo microdialysis and postmortem tissue analysis of amygdala endocannabinoid levels after MAGL- and FAAH-inhibition in rodents
Neurochemistry International · 2025
DOI: 10.1016/j.neuint.2025.106006 ↗Kurz gefasst
Fachartikel in der Zeitschrift Neurochemistry International, 2025. Verfasst von Mariette S Heins und 4 weiteren Autor:innen. Beteiligte Einrichtung: Charles River Laboratories, Discovery Services, De Mudden 16, 9747 AW, Groningen, the Netherlands. Hauptthemen laut MEDLINE: Endocannabinoids, Amidohydrolases, Amygdala, Monoacylglycerol Lipases. Die Arbeit nennt 47 Literaturangaben. Gefördert von: Boehringer Ingelheim.
Abstract (Originalsprache)
This study is the first to investigate the target modulation of the MAGL inhibitor elcubragistat (ABX-1431; Lu-AG06466) and the FAAH inhibitor JNJ-42165279 in the amygdala, a brain region involved in stress-induced psychiatric disorders. We aimed to assess dynamic changes in the endocannabinoid ligands 2-arachidonoylglycerol (2-AG) and anandamide (AEA) following pharmacological inhibition of MAGL and FAAH, enzymes regulating their metabolism. Freely moving rats received oral doses of elcubragistat or JNJ-42165279. Microdialysis probes in the basolateral amygdala and nucleus accumbens measured extracellular 2-AG and AEA levels over 240 min using LC-MS/MS. A supplementary mouse study analyzed postmortem endocannabinoid levels in the basolateral amygdala. MAGL inhibition by elcubragistat selectively increased extracellular and tissue 2-AG levels in the basolateral amygdala in a dose-related manner without affecting AEA. Conversely, FAAH inhibition by JNJ-42165279 selectively elevated AEA levels without altering 2-AG. Highest endocannabinoid concentration in basolateral amygdala tissue was between 2 and 4 h after MAGL or FAAH inhibition. In vivo microdialysis is a sensitive method to study target modulation of both MAGL and FAAH inhibitors in the amygdala of freely moving rats. The results of the microdialysis study are in general agreement with postmortem tissue analysis of both 2-AG and AEA and suitable to support the preclinical drug discovery process in concert with disease related animal models.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Charles River Laboratories, Discovery Services, De Mudden 16, 9747 AW, Groningen, the Netherlands.
- Mathison Centre for Mental Health Research and Education, University of Calgary, 3280 Hospital DR NW, T2N5A1, Calgary, Canada; University of Ulm, Department for Child and Adolescent Psychiatry/Psychosomatics/Psychothera…
- Boehringer Ingelheim, Neuroscience and Mental Health DR, Birkendorfer Str. 65, 88397, Biberach, Germany.
- University of Groningen, Department of Analytical Biochemistry, A Deusinglaan 1, 9714 AV, Groningen, the Netherlands; Quantall Holding, Groningen, the Netherlands.
- Ulm University Medical Center, Institute of Experimental and Clinical Pharmacology, Toxicology and Pharmacology of Natural Products, Albert-Einstein-Allee 11, 89081, Ulm, Germany. Electronic address: boris.ferger@uni-ul…
Förderung
- Boehringer Ingelheim
Zitieren
APA
Heins, M. S., Ferger, M. D., Voehringer, P., Cremers, T. I. F. H., & Ferger, B. (2025). Neurochemical in vivo microdialysis and postmortem tissue analysis of amygdala endocannabinoid levels after MAGL- and FAAH-inhibition in rodents. Neurochemistry International. https://doi.org/10.1016/j.neuint.2025.106006
Vancouver
Heins MS, Ferger MD, Voehringer P, Cremers TIFH, Ferger B. Neurochemical in vivo microdialysis and postmortem tissue analysis of amygdala endocannabinoid levels after MAGL- and FAAH-inhibition in rodents. Neurochemistry International. 2025. doi:10.1016/j.neuint.2025.106006
BibTeX
@article{Heins2025,
author = {Heins, Mariette S and Ferger, Marc D and Voehringer, Patrizia and Cremers, Thomas I F H and Ferger, Boris},
title = {Neurochemical in vivo microdialysis and postmortem tissue analysis of amygdala endocannabinoid levels after MAGL- and FAAH-inhibition in rodents},
journal = {Neurochemistry International},
year = {2025},
doi = {10.1016/j.neuint.2025.106006}
}
EUVIMED